Malaria vaccine
    2.
    发明授权
    Malaria vaccine 失效
    疟疾疫苗

    公开(公告)号:US4466917A

    公开(公告)日:1984-08-21

    申请号:US234096

    申请日:1981-02-12

    摘要: The present invention provides antisera and monoclonal antibodies directed against the sporozoite stage of the malaria parasite capable of providing protection against infection in both animals and humans. The invention further provides a purified antigen derived from sporozoites of the malaria parasite, the antigen being suitable for use as a vaccine against malarial infections in both animals and humans. The invention further provides means for preparing said antigen and a vaccine comprising said antigen.

    摘要翻译: 本发明提供针对疟疾寄生虫的子孢子阶段的抗血清和单克隆抗体,其能够提供对动物和人类的感染的保护。 本发明进一步提供了源自疟原虫子孢子的纯化抗原,该抗原适合用作抗动物和人类疟疾感染的疫苗。 本发明还提供了制备所述抗原和包含所述抗原的疫苗的方法。